Page 12 - Score Test News Today

Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) General Counsel James Herriott sold 1,300 shares of the stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $100.00, for a total transaction of $130,000.00. Following the completion of the transaction, the general counsel now owns 5,964 […]

Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) General Counsel James Herriott sold 1,300 shares of the business’s stock in a transaction that occurred on Wednesday, July 19th. The shares were sold at an average price of $100.00, for a total value of $130,000.00. Following the completion of the transaction, the general counsel now directly […]

Gratus Capital LLC acquired a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the 1st quarter, Holdings Channel reports. The fund acquired 5,000 shares of the medical research company’s stock, valued at approximately $339,000. Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. American […]

Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target raised by Craig Hallum from $85.00 to $106.00 in a research report report published on Thursday, The Fly reports. A number of other analysts have also recently weighed in on the company. Benchmark increased their price target on Exact Sciences from $81.00 to $96.00 in […]

Exact Sciences (NASDAQ:EXAS – Get Rating) had its target price lifted by Benchmark from $81.00 to $96.00 in a report released on Thursday, The Fly reports. EXAS has been the topic of a number of other reports. Credit Suisse Group restated a neutral rating and set a $70.00 price target on shares of Exact Sciences […]

1-800-FLOWERS.COM restated their reiterates rating on shares of Exact Sciences (NASDAQ:EXAS – Get Rating) in a research report released on Thursday morning, Benzinga reports. Other equities analysts have also issued research reports about the company. BTIG Research boosted their price objective on Exact Sciences from $95.00 to $110.00 in a research note on Thursday. Cowen […]

Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective raised by Benchmark from $81.00 to $96.00 in a research note issued to investors on Thursday, The Fly reports. EXAS has been the subject of a number of other reports. Craig Hallum upgraded shares of Exact Sciences from a hold rating to a buy rating […]

Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target boosted by Stifel Nicolaus from $85.00 to $120.00 in a report released on Thursday, The Fly reports. A number of other research analysts have also recently commented on the stock. Piper Sandler increased their price target on shares of Exact Sciences from $70.00 to $80.00 […]

Exact Sciences (NASDAQ:EXAS – Get Rating) had its target price increased by analysts at Benchmark from $81.00 to $96.00 in a research note issued to investors on Thursday, The Fly reports. Benchmark’s target price indicates a potential upside of 3.65% from the stock’s previous close. Several other analysts have also recently issued reports on the […]

Exact Sciences Co. (NASDAQ:EXAS – Get Rating) – SVB Leerink increased their Q2 2023 earnings per share estimates for Exact Sciences in a research note issued to investors on Tuesday, June 20th. SVB Leerink analyst P. Souda now anticipates that the medical research company will post earnings per share of ($0.50) for the quarter, up […]